Klaria Pharma Holding AB (publ.) reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported revenue was SEK 3.71 million. Net loss was SEK 14.51 million compared to SEK 15.93 million a year ago. Basic loss per share from continuing operations was SEK 0.24.
For the six months, revenue was SEK 4.08 million compared to SEK 31.31 million a year ago. Net loss was SEK 34.77 million compared to net income of SEK 0.778 million a year ago. Basic loss per share from continuing operations was SEK 0.61.